| HOME >> BIOLOGY >> TECHNOLOGY |
TABLE 129 GLOBAL PROTEOMICS APPLICATIONS MARKET THROUGH 2014 ($ MILLIONS)
DRUG DISCOVERY
TABLE 130 GLOBAL DRUG DISCOVERY APPLICATIONS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS)
MARKET DRIVERS
Shortcomings of Gene-Based Drug Discovery Igniting Adoption of Proteomics
Benefits Derived through Protein-Based Drug Design and Discovery Are Expected to Be the Key Factor Contributing to Growth of Proteomics in the Drug Discovery Market
Need to Understand the Dynamics of Protein Element
Continuous Search for Alternative and Efficient Methods to Deliver Enhanced Drugs
Increasing R&D Investments from Pharmaceutical and Biotech Companies
Potential Market in Growing Economies
Emerging Approaches and Innovations in Proteomics Improving Decision Support Tools
MARKET INHIBITORS
Lack of Enhanced Computational Tools Limiting the Scope of Effective Analysis
Limited Drug Alternatives Restricting the Scope of Proteomics
Prevailing Skepticism on the Feasibility of Manufacturing Protein-Based Drugs on Larger Levels, Impairing the Adoption of Proteomics
Limited Utility of Proteomics Due to Complexity Involved and Lack of Adequately Trained Manpower
DRUG DEVELOPMENT
DRUG TARGET VALIDATION
MARKET DRIVERS
Advantages of Target-Based Drug Discovery Leading to Profuse Investment from Drug Development Companies
Application of Proteomics Enabling Process Efficiency
Limited Knowledge on Protein Dynamics Limits High-Level Application
ADME-TOX Profiling
Target Identification
DIAGNOSIS MARKET
TABLE 131 GLOBAL DIAGNOSIS APPLICATIONS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS)
MARKET DRIVERS
Better Analysis of Kidney Diseases by Proteomics Supports Its Growth in Clin
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |